Utah Medical Products Inc income statement
In fiscal 2025, Utah Medical Products Inc reported revenue of $38.5m, down 5.8% on the year before, operating income of $11.4m (a 29.6% margin) and net income of $11.3m, or $3.48 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26 | 25 | 38 | 42 | 40 | 41 | 40 | 39 | 41 | 42 | 47 | 42 | 49 | 52 | 50 | 41 | 39 | 36 |
| Cost of revenue | — | — | — | — | — | — | — | 16 | 15 | 16 | 17 | 17 | 18 | 20 | 20 | 17 | 17 | 15 |
| Gross profit | 14 | 13 | 22 | 25 | 24 | 25 | 24 | 24 | 26 | 26 | 29 | 26 | 31 | 32 | 30 | 24 | 22 | 21 |
| Research and development | 0 | 0 | −1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 |
| Selling and marketing | 2 | 2 | −3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | — |
| General and administrative | 2 | 2 | −7 | 7 | 6 | 6 | 6 | 5 | 5 | 5 | 10 | 10 | 10 | 10 | 11 | 8 | 8 | — |
| Operating income | 9 | 9 | 12 | 15 | 15 | 16 | 16 | 16 | 19 | 19 | 18 | 14 | 19 | 20 | 17 | 14 | 11 | 10 |
| Interest expense | 0 | 0 | 1 | 1 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — |
| Income before tax | 10 | 9 | 11 | 15 | 14 | 16 | 16 | 16 | 19 | 19 | 18 | 14 | 19 | 21 | 20 | 17 | 14 | 13 |
| Income tax | 3 | 3 | 4 | 4 | 3 | 4 | 4 | 4 | 11 | 1 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 2 |
| Net income | 6 | 6 | 7 | 10 | 11 | 11 | 12 | 12 | 9 | 19 | 15 | 11 | 15 | 16 | 17 | 14 | 11 | 10 |
| Diluted EPS | $1.72 | $1.65 | $2.03 | $2.74 | $3.02 | $3.02 | $3.14 | $3.22 | $2.28 | $4.95 | $3.94 | $2.94 | $4.04 | $4.52 | $4.57 | $3.96 | $3.48 | $3.28 |
| Diluted shares (average) | — | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 4m | 3m | 3m |
| EBITDA | 10 | 9 | 13 | 16 | 15 | 17 | 16 | 17 | 20 | 19 | 18 | 14 | 20 | 20 | 17 | 14 | 12 | 11 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 9 | 10 | 10 | 10 | 9 | 9 | 9 |
| Cost of revenue | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 |
| Gross profit | 6 | 5 | 6 | 6 | 6 | 5 | 5 | 5 |
| Research and development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 2 | — | 2 | 2 | 3 | — | 3 | 2 |
| Operating income | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 |
| Income before tax | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
| Income tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net income | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Diluted EPS | $1.03 | $0.86 | $0.92 | $0.94 | $0.82 | $0.80 | $0.82 | $0.84 |
| EBITDA | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Compare with peers
- Electrocore, Inc. income statement
- Cytosorbents Corp income statement
- Retractable Technologies Inc income statement
- Orchestra Biomed Holdings, Inc. income statement
- Precision Optics Corporation, Inc. income statement
Head to head: ECOR vs UTMDCTSO vs UTMDRVP vs UTMD
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies